arrow_back Trending Legislation
Share share

Faster Access to Innovative Medical Technologies for Seniors

This act aims to accelerate Medicare beneficiaries' access to new, breakthrough medical technologies. It will allow innovative medical devices to be made available to patients more quickly, potentially improving their healthcare quality and treatment outcomes. These changes are designed to ensure that the latest medical advancements reach those in need without unnecessary delays.
Key points
Expedited introduction of innovative medical devices into the Medicare program, meaning patients will have earlier access to them.
Enabling conditional approval for breakthrough medical devices under the Medicare New Technology Add-On Payment (NTAP) program, even if the full FDA approval process is not yet complete.
The changes are intended to be budget-neutral, meaning they should not generate additional costs for taxpayers within the Medicare program.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Patient Access to Innovative New Technologies Act of 2024
Print number: HR 7939
Sponsor: Rep. Carey, Mike [R-OH-15]
Process start date: 2024-04-11
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Faster Access to Innovative Medical Technologies for Seniors

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7939.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-04-11.

What are the main provisions?

Key points include:

  • Expedited introduction of innovative medical devices into the Medicare program, meaning patients will have earlier access to them.
  • Enabling conditional approval for breakthrough medical devices under the Medicare New Technology Add-On Payment (NTAP) program, even if the full FDA approval process is not yet complete.
  • The changes are intended to be budget-neutral, meaning they should not generate additional costs for taxpayers within the Medicare program.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carey, Mike [R-OH-15].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 7939

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health